Vertex Gets Approval In Canada For Expanded Use Of Cystic Fibrosis Drug Kalydeco
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) said on Friday that Kalydeco has won regulatory approval in Canada for expanded use in cystic fibrosis patients between
Source: finanznachrichten.de